INCREASED CSF LEVELS OF BIOMARKERS FOR NEURODEGENERATION IN FTLD-GRN MUTATION CARRIERS Joery Goossens, Sara Van Mossevelde, Tobi Van den Bossche, Anne Sieben, Jean-Jacques Martin, Johan Goeman, Peter Paul de Deyn, Christine Van Broeckhoven, Julie van der Zee, Sebastiaan Engelborghs Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 12, Issue 7, Pages P1058-P1059 (July 2016) DOI: 10.1016/j.jalz.2016.06.2211 Copyright © 2016 Terms and Conditions
Figure 1 Cox hazard regression analysis of disease duration in GRN carriers (n=59) versus C9orf72 carriers (n=53) with pure dementia (p=0.051), corrected for age at onset. Numbers include deceased patients (GRN: n=40; C9orf72: n=30) and living patients censored at time of last evaluation (GRN: n=19; C9orf72: n=23). Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, P1058-P1059DOI: (10.1016/j.jalz.2016.06.2211) Copyright © 2016 Terms and Conditions